Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2012) 29 P1409

ICEECE2012 Poster Presentations Pituitary Clinical (183 abstracts)

Increased risk of hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors with the use of concurrent chemo-irradiation

J Ratnasingam , N Karim , S Paramasivam , A Tan Tong Boon , S Vethakkan , K Choong , R Pendek & S Chan


University Malaya, Kuala Lumpur, Malaysia.


Background: Radiotherapy is the mainstay of NPC (nasopharyngeal carcinoma) treatment and recently there is increased use of concurrent chemo-irradiation (CCRT) to improve survival. The irradiation field for NPC includes the base of skull, risking radiation damage to the hypothalamic–pituitary (HP) axis.

Aims: To evaluate the prevalence of HP dysfunction in NPC survivors post-irradiation and to compare the risk of developing HP dysfunction amongst patients who had CCRT versus radiotherapy alone.

Methods: We recruited 58 patients (33 males/25 females) with no known hormonal dysfunction, who completed radiotherapy for NPC more than 3 years ago. All patients had baseline cortisol, ACTH, GH, IGF1, fT4, TSH, FSH, LH, oestradiol/testosterone and prolactin measured at 8am after an overnight fast. In addition 49 of the 58 patients underwent dynamic testing with the insulin tolerance test (ITT).

Results: All patients received a standard dose of external beam radiotherapy of 70 Gy to the posterior nasal space. 43 patients received concurrent chemo-irradiation while 15 had radiotherapy alone. Median age: 56 (48.75–63.25) years and median time post-irradiation 8 (6.0–11.25) years. Hypopituitarism was present in 84% of patients, 31% with involvement of a single axis, 29% with two axes, 18% with three axes and 6% with four axes. The prevalence of GH, corticotroph, gonadotroph, thyrotroph deficiency and hyperprolactinaemia was 80, 41, 19, 3 and 25% respectively. The development of HP dysfunction was significantly associated with the use of CCRT when compared with the radiotherapy alone group, OR: 14.57 (2.42–28.6), P=0.01.

Conclusion: HP dysfunction post-irradiation is widespread amongst NPC survivors with the most common being GH-deficiency. Radiation-induced damage appears to be profoundly increased with the use of radio-sensitising chemotherapy. As these endocrinopathies result in significant morbidity/mortality we recommend periodic assessment of pituitary function post-irradiation.

Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.

Funding: This work was supported, however funding details unavailable.

Volume 29

15th International & 14th European Congress of Endocrinology

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.